Josep M. Gatell
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
48 Week body composition changes in persons with HIV switching to dolutegravir plus lamivudine: a planned subanalysis of the DOLAM randomized clinical trial.
Journal: The Journal of antimicrobial chemotherapy
Published: January 12, 2025
Effective Treatment of Lymphogranuloma venereum Proctitis With Azithromycin.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 13, 2020
A Classifier to Predict Viral Control After Antiretroviral Treatment Interruption in Chronic HIV-1-Infected Patients.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: January 07, 2020
Virological Outcome Measures During Analytical Treatment Interruptions in Chronic HIV-1-Infected Patients.
Journal: Open forum infectious diseases
Published: May 27, 2019
Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection.
Journal: AIDS (London, England)
Published: October 06, 2018
Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults.
Journal: Enfermedades infecciosas y microbiologia clinica (English ed.)
Published: March 08, 2018
Polypharmacy and potential drug-drug interactions in an HIV-infected elderly population
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: November 08, 2017
Polypharmacy and potential drug-drug interactions in an HIV-infected elderly population.
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: August 30, 2017
New challenges in therapeutic vaccines against HIV infection.
Journal: Expert review of vaccines
Published: April 23, 2017
Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
Journal: Enfermedades infecciosas y microbiologia clinica (English ed.)
Published: February 24, 2017
Atherogenic properties of LDL particles after switching from Truvada or Kivexa plus lopinavir/r to lamivudine plus lopinavir/r: OLE-MET substudy.
Journal: HIV clinical trials
Published: January 14, 2017
Last Updated: 09/26/2026